Amedisys, Inc. (NASDAQ:AMED) Shares Sold by Fmr LLC

Fmr LLC trimmed its position in Amedisys, Inc. (NASDAQ:AMED) by 50.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,213 shares of the health services provider’s stock after selling 3,283 shares during the quarter. Fmr LLC’s holdings in Amedisys were worth $310,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. KBC Group NV purchased a new position in Amedisys in the third quarter valued at $63,000. Innealta Capital LLC purchased a new position in shares of Amedisys in the 2nd quarter valued at about $64,000. Signaturefd LLC raised its position in shares of Amedisys by 88.2% during the 2nd quarter. Signaturefd LLC now owns 1,131 shares of the health services provider’s stock worth $104,000 after acquiring an additional 530 shares in the last quarter. CWM LLC lifted its stake in Amedisys by 14.5% during the third quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock worth $211,000 after purchasing an additional 277 shares during the last quarter. Finally, Crossmark Global Holdings Inc. purchased a new stake in shares of Amedisys during the 3rd quarter worth approximately $243,000. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Amedisys Stock Performance

Shares of AMED stock opened at $84.47 on Friday. The firm has a market cap of $2.77 billion, a price-to-earnings ratio of 33.52, a PEG ratio of 1.84 and a beta of 0.73. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. Amedisys, Inc. has a 1 year low of $82.15 and a 1 year high of $98.95. The stock’s 50-day moving average is $91.75 and its two-hundred day moving average is $94.68.

Amedisys (NASDAQ:AMED) last issued its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). The business had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The firm’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.98 EPS. Analysts predict that Amedisys, Inc. will post 4.45 earnings per share for the current year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.